Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Geopolitics Continues to Roil the Fortunes of Qualcomm Stock

After a much-needed U.S.-China phase one agreement, Qualcomm stock looked poised for growth. However, the coronavirus has disrupted this previously positive narrative.

Bitcoin Halving: What It Is and What It Means for You

Very shortly, bitcoin will incur a halving event. But what does this mean and how will it impact your cryptocurrency holdings?

Royal Caribbean Stock is Lost in Rough Seas

RCL stock has moved significantly higher since hitting a bottom this year. However, investors shouldn’t be buoyed – the cruise industry is probably the worst of this economy.

Shopify’s Premium Is a Symptom of Our Social Disconnect

Given the remarkable rise of Shopify stock amid the coronavirus pandemic, many have openly wondered about its sustainability. What those folks are not considering is that SHOP is a reflection of our economic bifurcation.

3 Reasons to Think Carefully Before Betting on UnitedHealth

Though coronavirus-driven health concerns may briefly drive UNH stock, the weakening economy could put a damper on this thesis.

3 Reasons to Leave CSX on the Tracks

CSX stock is essentially where the economic rubber meets the road. Based on the present situation, that is ominous for the railroad transportation specialist.

10 Key Stocks to Watch Over the Next Few Months

Because government economic reports are always lagging, investors are fretting over the coming second-quarter figures. But these 10 stocks to watch provide a close-to-real-time indication of sentiment.

Don’t Book a Position on Delta Air Lines Just Yet

For DAL stock, the loss of consumer confidence is already bad enough. But gauging their willingness to board airplanes with strangers adds a whole new level of anxiety.

Inovio Pharmaceuticals Is Hurting From Remdesivir but It’s Still Standing

With White House health advisor Dr. Anthony Fauci’s endorsement of Gilead Sciences’ remdesivir, INO stock now seems irrelevant. But that might not be accurate if you look at the broader context.

Co-Diagnostics Is Becoming More Relevant

A no-name investment in 2019, CODX stock has emerged as one of the most relevant players as Covid-19 diagnostics take center stage.